Drug Profile
Imagabalin - Pfizer
Alternative Names: PD 0332334; PD-332334; PF-00195889Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Pfizer
- Class Anxiolytics; Small molecules
- Mechanism of Action GABA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Generalised anxiety disorder
Most Recent Events
- 25 Feb 2009 Discontinued - Phase-III for Generalised anxiety disorder in Hungary (PO)
- 25 Feb 2009 Discontinued - Phase-III for Generalised anxiety disorder in Italy (PO)
- 25 Feb 2009 Discontinued - Phase-III for Generalised anxiety disorder in Russia (PO)